Key result
Three different nucleic acid extraction assays correctly identified >95% of T. cruzi-positive sera, with detection rates ranging from 96.8% to 100%.
Why the study?
Do different nucleic acid extraction assays influence the sensitivity of T. cruzi-specific real-time PCR in reference sera?
Do different nucleic acid extraction assays influence the sensitivity of T. cruzi-specific real-time PCR in reference sera?
Different nucleic acid extraction assays are generally suitable for T. cruzi-specific PCR from serum, though minor differences in sensitivity and Ct values may impact diagnosis in patients with low parasitemia.
Extraction method choice may alter T. cruzi PCR sensitivity in serum; leaves open optimal protocols for Chagas molecular diagnosis.
For the molecular diagnosis of Chagas disease by real-time PCR (polymerase chain reaction), optimization of diagnostic accuracy is desirable. The detection limit of real-time PCR assays for the diagnosis of Trypanosoma cruzi in human serum is affected by various influences including the choice of the nucleic acid extraction assay. In this study, three nucleic acid extraction assays were compared regarding their influence on the sensitivity of a T. cruzi-specific real-time PCR with 62 reference sera containing T. cruzi target DNA (deoxyribonucleotide acid). More than 95% of the positive sera were correctly identified after all three nucleic acid extraction strategies with a detection rate ranging from 96.8% (60/62) for the worst assay to 100% (62/62) for the best one. A matched pairs analysis for the comparison of the cycle threshold (Ct) values obtained with the 59 reference samples with positive real-time PCR results after all three nucleic acid extraction schemes indicated differences in a range of about 3 Ct steps. Summarized, all three compared nucleic acid extraction schemes were basically suitable for T. cruzi-specific PCR from serum with some minor differences. However, in the case of low quantities of circulating parasite DNA in the serum of a patient with Chagas disease, even minor effects can make a difference in the individual diagnosis.
No takes yet. Share an insight, caveat, or question.
Kann et al. (2022) studied Chagas disease (n=62). Different nucleic acid extraction assays was evaluated on Detection rate of T. cruzi target DNA. Three different nucleic acid extraction assays correctly identified >95% of T. cruzi-positive sera, with detection rates ranging from 96.8% to 100%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: